Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3493841000168110 | Karvezide 150/12.5 (hydrochlorothiazide 12.5 mg + irbesartan 150 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3493851000168112 | Karvezide 150/12.5 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Karvezide 150/12.5 tablet, 30, blister pack | has TPUU | True | Karvezide 150/12.5 tablet | Inferred relationship | Some | 1 |
Karvezide 150/12.5 tablet, 30, bottle | has TPUU | True | Karvezide 150/12.5 tablet | Inferred relationship | Some | 1 |
Karvezide 150/12.5 tablet, 30 | has TPUU | True | Karvezide 150/12.5 tablet | Inferred relationship | Some | 1 |
Karvezide 150/12.5 tablet, 30, blister pack | has TPUU | False | Karvezide 150/12.5 tablet | Inferred relationship | Some |
Reference Sets
Trade product unit of use reference set